comparemela.com

நீதிபதி ஜெனிபர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hikma Should Face Amarin s Patent Suit, Magistrate Says

Law360 ADVERTISEMENT Hikma Should Face Amarin s Patent Suit, Magistrate Says Law360 (August 3, 2021, 8:54 PM EDT) Hikma Pharmaceuticals should not be able to dodge a lawsuit claiming it encouraged doctors to prescribe its generic version of the heart drug Vascepa for uses covered by a series of Amarin patents, a Delaware federal magistrate judge says. Magistrate Judge Jennifer L. Hall on Tuesday issued a report and recommendation in a lawsuit filed by Amarin Pharma Inc., Amarin Pharmaceuticals Ireland Ltd. and Mochida Pharmaceutical Co. Ltd. alleging that Hikma induced infringement of three patents. Specifically, Amarin alleged in the so-called skinny label case that Hikma induced doctors to infringe the patents by instructing them to use the Hikma generic.

CBD And Hemp Legal And Regulatory Roundup – July 16, 2021 - Cannabis & Hemp

CBD And Hemp Legal And Regulatory Roundup – July 16, 2021 - Cannabis & Hemp
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.

Viewpoint: Candidates starting to line up for fall municipal elections

Viewpoint: Candidates starting to line up for fall municipal elections
uptownmessenger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uptownmessenger.com Daily Mail and Mail on Sunday newspapers.

FlatWing Denied Atty Fees In Patent Fight With Pfizer Unit

A federal magistrate judge has recommended against shifting nearly $690,000 in fees and expenses to Pfizer unit Anacor Pharmaceuticals from a company that challenged Anacor's patent for a toenail fungus treatment, citing an absence of evidence that Anacor pursued unreasonable infringement claims or patent defenses.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.